FRANKLIN LAKES, N.J.,
Aug. 17, 2020 /PRNewswire/ -- BD
(Becton, Dickinson and Company) (NYSE: BDX), a leading global
medical technology company, announced today the appointment of
Kristen Stewart to the newly created
position of senior vice president of Strategy and Investor
Relations.
In this role, Stewart will partner closely with the BD executive
team to drive shareholder value and to deliver and communicate the
company's long-term growth strategy.
Stewart will add to BD her extensive experience as a seasoned
health care analyst specializing in medical technology, which she
gained working at several premier Wall Street investment banks for
nearly two decades. She most recently led the medical technology
research franchise at Barclays Capital. She has been recognized by
Institutional Investor as one of the top three analysts in
the Medical Supplies & Devices category several times during
her career.
"As a highly respected analyst in our sector, Kristen brings a
deep understanding of the medical technology industry to BD," said
Tom Polen, CEO and president. "I am
confident her strong strategic and analytical skills will serve the
company and our stakeholders tremendously well, and I look forward
to her partnership as we continue to execute our strategy."
Stewart said, "I have watched through the analyst lens as BD has
transformed into a global medical technology innovator. I am
excited by BD's current strategic direction and believe the company
has significant potential to optimize shareholder value. I am
thrilled to undertake this important new role."
Christopher Reidy, executive vice
president, CFO and chief administrative officer, said, "Kristen's
wealth of experience and long-standing relationships throughout the
investment community will bring meaningful value to BD. I am
excited about the alignment of both strategy and IR under Kristen's
leadership and look forward to welcoming her to the team."
Stewart began her financial career at PricewaterhouseCoopers.
She is a chartered financial analyst and is an inactive certified
public accountant.
Stewart will join BD on Aug. 31,
2020 and report to Chris
Reidy.
About BD
BD is one of the largest global medical technology companies in the
world and is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. The company
supports the heroes on the frontlines of health care by developing
innovative technology, services and solutions that help advance
both clinical therapy for patients and clinical process for health
care providers. BD and its 65,000 employees have a passion and
commitment to help enhance the safety and efficiency of clinicians'
care delivery process, enable laboratory scientists to accurately
detect disease and advance researchers' capabilities to develop the
next generation of diagnostics and therapeutics. BD has a presence
in virtually every country and partners with organizations around
the world to address some of the most challenging global health
issues. By working in close collaboration with customers, BD can
help enhance outcomes, lower costs, increase efficiencies, improve
safety and expand access to health care. For more information on
BD, please visit bd.com.
Contacts:
|
|
|
|
Kristen
Cardillo
|
Tony Di
Meo
|
BD Public
Relations
|
BD Investor
Relations
|
201.847.5657
|
201.847.4166
|
kristen.cardillo@bd.com
|
Anthony_Di_Meo@bd.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/kristen-stewart-to-join-bd-as-senior-vice-president-of-strategy-and-investor-relations-301113441.html
SOURCE BD (Becton, Dickinson and Company)